A Phase 2 Trial to evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke

Sponsor: Dart NeuroScience
Principal Investigator: Courtney Takahashi MD
Sub-Investigators: Brigid Dwyer MD, Julie Grimes MD

Study information pending